Health Spirit Body

Menu
  • Home
  • Health
  • Weight Loss
  • Nutrition
Home
Health
Magic Mushroom Named A ‘Breakthrough Therapy’ For Depression By FDA
Health

Magic Mushroom Named A ‘Breakthrough Therapy’ For Depression By FDA

Don Patrick November 1, 2018

The ‘magic mushroom’ chemical, psilocybin, has been named a Breakthrough Therapy by the FDA, expediting research on its use to treat depression.

The designation was introduced in 2012 and is reserved only for treatments for serious and life-threatening conditions that may be better than existing ones.

Psilocybin is a Schedule I drug, according to the Drug Enforcement Administration (DA), but it and several other psychedelic drugs have lately gained traction as promising mental illness treatments.

In August, a trial of psilocybin got the FDA’s approval for the first time ever.

The trial’s results thus far have apparently been so promising for patients with treatment-resistant depression that the agency has now given it the rare classification, which could cut the time it takes to get approved in half.

magic mushroom depression breakthrough therapy

Psilocybin, the active chemical in psychedelic ‘magic mushrooms’ has shown so much promise for treating depression that the FDA has now classified it a breakthrough therapy, which should expedite the drug’s development

Depression is exceedingly common in the US, yet many patients never feel like they find effective treatment.

Some 40 million adults suffer from some degree or form of depression. It is widely accepted that a combination of talk therapy and medication is most beneficial to the majority of patients with depression, but even the two-pronged attack fails for many.

Between 10 and 30 percent of these people don’t find relief from traditional medications, such as commonly prescribed selective serotonin reuptake inhibitors (SSRIs).

There are about 10 other classes of antidepressant drugs, but for some patients, they all fail.

And even when they work, it may take patients months to feel the effects and that relief may come with unpleasant – and sometimes unbearable – side effects, like nausea, insomnia, and sexual dysfunction.

Psilocybin is radically different from these existing treatments.

While SSRIs and other approved antidepressants are thought to work by making the brain’s emotional center, the amygdala, less sensitive to intense negative feelings.

Psilocybin seems to do the opposite.

In brain scans of patients who have been given the experimental depression treatment, psilocybin appears to encourage emotional activity in the amygdala.

Yet, somehow, patients are then better able to process these feelings and feel relief from their depressive symptoms mere weeks later.

Other research has suggested that the drug ‘resets’ neural circuits that create negative feedback loops in patients’ brains.

The growing body of evidence supporting the usefulness of psilocybin led the FDA to give Peter Thiel-backed Compass Pathways the go-ahead to expand its clinical trial of the compound to the US in August.

Compass was then about to begin a UK trial and was soon to start tests in Canada and the Netherlands as well.

magic mushroom depression breakthrough therapy

Billionaire Peter Thiel backs Compass Pathways and its psilocybin treatment for depression

Now, a mere three months later, the FDA has designated psilocybin a Breakthrough Therapy, a distinction that should shorten the period between its current trials and broader patient access to the therapy.

This decision has a number of important implications for both psilocybin and depression itself.

First of all, the FDA only gives breakthrough classification for therapies ‘to treat serious or life-threatening disease or condition,’ according to the agency’s website.

It has only been in recent history that depression was widely treated as a medical condition. Now, the FDA considers it ‘serious or life-threatening,’ which signals a shifting perspective on its gravity.

Psilocybin is not the first depression treatment to get be designated a breakthrough, but it is unique – and presents a bit of a bureaucratic conundrum.

Currently, the DEA classifies it a Schedule I drug, meaning that, like heroin, it has demonstrated medical uses.

But now, the FDA, another government agency, is saying otherwise.

What’s more, by calling psilocybin a Breakthrough Therapy, the FDA is promising to speed up its development.

On average, it takes about 12 years to get a drug approved by the FDA. Being designated a Breakthrough Therapy cuts that time down to 5.7 years – less than half the time it would normally take.

The designation signals, too, that psilocybin may actually be more effective for treating some of the most difficult cases of depression than drugs already on the market.

In a statement, Compass Pathways executive chairman George Goldsmith called the designation ‘great news for patients.’

‘We are excited to be taking this work forward with our clinical trial on psilocybin therapy for treatment-resistant depression.

‘The FDA will be working closely with us to expedite the development process and increase the chances of getting this treatment to people suffering from depression as quickly as possible.’

If you know someone who might like this, please click “Share”!

Share
Tweet
Email
Prev Article
Next Article

Related Articles

how to fight loneliness in winter
The cold winter months can be a difficult time. Add …

9 Tips On How To Fight Loneliness In Winter Season

beach benefits
Scientists Reveal How Visiting The Beach Changes Your Brain It …

Scientists Reveal How Visiting The Beach Changes Your Brain

weed-wine
How many of you stoners out there would also consider …

If Being Drunk And High At The Same Time Sounds Appealing, Say Hello To Weed-Wine

How To Tell If Your Personal Trainer Is Attracted To You
Have you ever felt like your personal trainer is attracted …

How To Tell If Your Personal Trainer Is Attracted To You 2022

Popular Posts

  • Can you eat pizza with braces
    Can You Eat Pizza With Braces? How …
    February 6, 2023 0
  • Why am I craving milk
    Why Am I Craving Milk? What Does …
    February 7, 2023 0
  • Do cherries make you poop
    Do Cherries Make You Poop? Everything Explained …
    February 9, 2023 0
  • Vaginal Whitening
    Vaginal Whitening: Safety Vaginal Bleaching Alternatives in …
    February 10, 2023 0
  • how to get rid of knee fat
    How to Get Rid of Knee Fat …
    February 11, 2023 0

Related Posts

  • beard bacteria
    Attention Hipsters: Science Confirms Beards Are Filled …
    November 9, 2021 0
  • smart people are lazier
    Science Says That Being Lazy May Be …
    October 18, 2021 0
  • sociopath
    Here Are 5 Undeniable Signs That You …
    October 25, 2021 0
  • knitting health benefits
    Knitting Can Have A Surprising Impact On …
    October 20, 2021 0
  • universe quotes
    100 Inspirational Quotes About the Universe
    July 22, 2022 0

Health Spirit Body

Health Information For A Better You
Copyright © 2023 Health Spirit Body
About | DMCA | Privacy Policy | Terms Of Use | Contact
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT